These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

375 related articles for article (PubMed ID: 23313192)

  • 1. Overexpression of parkin in the rat nigrostriatal dopamine system protects against methamphetamine neurotoxicity.
    Liu B; Traini R; Killinger B; Schneider B; Moszczynska A
    Exp Neurol; 2013 Sep; 247():359-72. PubMed ID: 23313192
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epothilone D prevents binge methamphetamine-mediated loss of striatal dopaminergic markers.
    Killinger BA; Moszczynska A
    J Neurochem; 2016 Feb; 136(3):510-25. PubMed ID: 26465779
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Co-administration of betulinic acid and methamphetamine causes toxicity to dopaminergic and serotonergic nerve terminals in the striatum of late adolescent rats.
    Killinger B; Shah M; Moszczynska A
    J Neurochem; 2014 Mar; 128(5):764-75. PubMed ID: 24151877
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dopamine and Methamphetamine Differentially Affect Electron Transport Chain Complexes and Parkin in Rat Striatum: New Insight into Methamphetamine Neurotoxicity.
    Bazylianska V; Sharma A; Chauhan H; Schneider B; Moszczynska A
    Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008791
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective vulnerability in striosomes and in the nigrostriatal dopaminergic pathway after methamphetamine administration : early loss of TH in striosomes after methamphetamine.
    Granado N; Ares-Santos S; O'Shea E; Vicario-Abejón C; Colado MI; Moratalla R
    Neurotox Res; 2010 Jul; 18(1):48-58. PubMed ID: 19760475
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methamphetamine oxidatively damages parkin and decreases the activity of 26S proteasome in vivo.
    Moszczynska A; Yamamoto BK
    J Neurochem; 2011 Mar; 116(6):1005-17. PubMed ID: 21166679
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regional heterogeneity of dopaminergic deficits in vervet monkey striatum and substantia nigra after methamphetamine exposure.
    Harvey DC; Laćan G; Melegan WP
    Exp Brain Res; 2000 Aug; 133(3):349-58. PubMed ID: 10958525
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurotoxicity to dopamine neurons after the serial exposure to alcohol and methamphetamine: Protection by COX-2 antagonism.
    Blaker AL; Rodriguez EA; Yamamoto BK
    Brain Behav Immun; 2019 Oct; 81():317-328. PubMed ID: 31228610
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methamphetamine and human immunodeficiency virus protein Tat synergize to destroy dopaminergic terminals in the rat striatum.
    Theodore S; Cass WA; Maragos WF
    Neuroscience; 2006 Feb; 137(3):925-35. PubMed ID: 16338084
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neonatal methamphetamine in the rat: evidence for gender-specific differences upon tyrosine hydroxylase enzyme in the dopaminergic nigrostriatal system.
    Gomes-da-Silva J; Perez-Rosado A; de Miguel R ; Fernandez-Ruiz J; Silva MC; Tavares MA
    Ann N Y Acad Sci; 2000 Sep; 914():431-8. PubMed ID: 11085342
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protective and restorative effects of the traditional Chinese medicine Jitai tablet against methamphetamine-induced dopaminergic neurotoxicity.
    Xu S; Tu S; Gao J; Liu J; Guo Z; Zhang J; Liu X; Liang J; Huang Y; Han M
    BMC Complement Altern Med; 2018 Feb; 18(1):76. PubMed ID: 29475448
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Single and binge methamphetamine administrations have different effects on the levels of dopamine D2 autoreceptor and dopamine transporter in rat striatum.
    Chauhan H; Killinger BA; Miller CV; Moszczynska A
    Int J Mol Sci; 2014 Apr; 15(4):5884-906. PubMed ID: 24717411
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of the neuropeptide somatostatin on methamphetamine and glutamate-induced neurotoxicity in the striatum of mice.
    Afanador L; Mexhitaj I; Diaz C; Ordonez D; Baker L; Angulo JA
    Brain Res; 2013 May; 1510():38-47. PubMed ID: 23524190
    [TBL] [Abstract][Full Text] [Related]  

  • 14. rAAV-mediated nigral human parkin over-expression partially ameliorates motor deficits via enhanced dopamine neurotransmission in a rat model of Parkinson's disease.
    Manfredsson FP; Burger C; Sullivan LF; Muzyczka N; Lewin AS; Mandel RJ
    Exp Neurol; 2007 Oct; 207(2):289-301. PubMed ID: 17678648
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increases in cytoplasmic dopamine compromise the normal resistance of the nucleus accumbens to methamphetamine neurotoxicity.
    Thomas DM; Francescutti-Verbeem DM; Kuhn DM
    J Neurochem; 2009 Jun; 109(6):1745-55. PubMed ID: 19457119
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methamphetamine causes degeneration of dopamine cell bodies and terminals of the nigrostriatal pathway evidenced by silver staining.
    Ares-Santos S; Granado N; Espadas I; Martinez-Murillo R; Moratalla R
    Neuropsychopharmacology; 2014 Apr; 39(5):1066-80. PubMed ID: 24169803
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The newly synthesized pool of dopamine determines the severity of methamphetamine-induced neurotoxicity.
    Thomas DM; Francescutti-Verbeem DM; Kuhn DM
    J Neurochem; 2008 May; 105(3):605-16. PubMed ID: 18088364
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Parkin-deficient rats are resistant to neurotoxicity of chronic high-dose methamphetamine.
    Sharma A; Bazylianska V; Moszczynska A
    Exp Neurol; 2021 Nov; 345():113811. PubMed ID: 34298012
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeted overexpression of the parkin substrate Pael-R in the nigrostriatal system of adult rats to model Parkinson's disease.
    Dusonchet J; Bensadoun JC; Schneider BL; Aebischer P
    Neurobiol Dis; 2009 Jul; 35(1):32-41. PubMed ID: 19348945
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recombinant AAV8-mediated intrastriatal gene delivery of CDNF protects rats against methamphetamine neurotoxicity.
    Wang L; Wang Z; Xu X; Zhu R; Bi J; Liu W; Feng X; Wu H; Zhang H; Wu J; Kong W; Yu B; Yu X
    Int J Med Sci; 2017; 14(4):340-347. PubMed ID: 28553166
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.